Ambu A/S (OTCMKTS:AMBBY – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.
Analyst Ratings
This is a breakdown of current ratings for Ambu A/S and Innovative Eyewear, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ambu A/S | 0 | 1 | 0 | 0 | 2.00 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
Valuation & Earnings
This table compares Ambu A/S and Innovative Eyewear”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ambu A/S | $894.37 million | 3.06 | $90.19 million | $0.30 | 38.80 |
| Innovative Eyewear | $2.66 million | 2.84 | -$7.59 million | ($1.29) | -0.67 |
Ambu A/S has higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than Ambu A/S, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
1.0% of Innovative Eyewear shares are held by institutional investors. 1.8% of Innovative Eyewear shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Risk and Volatility
Ambu A/S has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.74, meaning that its share price is 174% more volatile than the S&P 500.
Profitability
This table compares Ambu A/S and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ambu A/S | 8.18% | 8.49% | 6.75% |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
Summary
Ambu A/S beats Innovative Eyewear on 9 of the 12 factors compared between the two stocks.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
